Olysio

Johnson & Johnson's Real Answer To Imminent Decline In Sales Of Top-Selling Drug
Seeking Alpha
Mon, 12/2/13 - 09:45 am
JNJ
Remicade
Olysio
hepatitis C
Keep An Eye On GW, Johnson & Johnson, Durata, and Merck Today
Motley Fool
Wed, 11/27/13 - 09:58 am
JNJ
Durata Therapeutics
Merck
GW Pharma
Olysio
Savitex
Noxafil
Dalvance
J&J, Medivir Win U.S. FDA Approval for Hepatitis C Pill
Bloomberg
Sat, 11/23/13 - 12:49 pm
JNJ
Medvir
hepatitis C
hepatitis
Olysio
simeprevir

Pages